Consistent with our previous findings, our results showed that TMZ or MTX administration, alone or in combination, significantly diminished (p < 0.001) the expression of serum levels of COMP, MMP1, and MMP3, compared to the FCA-induced RA model. This evidence concerns the gene MMP1 and rheumatoid arthritis.